Prostate cancer is still one of the most popular diseases with a high mortality rate all over the world, so that more efficient treatment approaches are extremely required, and polymeric-based nanoparticles may represent a more non-invasive smart carrier that can increase selectivity and reduce adverse reactions in addition to the possibility for a more prolonged drug release profile. This review aims to highlight the role of biodegradable polymeric-based nanoparticles as a potential platform for long-term prostate cancer treatment.
Basam Mahmoud Kasem (2026) studied this question.